Victoria Peter Etuk, Charity Sanni, Oluwafemi Omonijo, Stella Ijioma Atema, Temitayo Lawal, Anthonia Murna Yashim-Ankut, Ifeyinwa Ejinkeonye, Henry Chijioke Onyegbutulem, Oyewole K Oyedele, Imoiboho Williams, Nifarta Peingurta Andrew, Evaezi Okpokoro
{"title":"尼日利亚联邦首都区艾滋病毒感染者接种 COVID-19 疫苗的比例和决定因素。","authors":"Victoria Peter Etuk, Charity Sanni, Oluwafemi Omonijo, Stella Ijioma Atema, Temitayo Lawal, Anthonia Murna Yashim-Ankut, Ifeyinwa Ejinkeonye, Henry Chijioke Onyegbutulem, Oyewole K Oyedele, Imoiboho Williams, Nifarta Peingurta Andrew, Evaezi Okpokoro","doi":"10.1093/trstmh/trae094","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We investigated coronavirus disease 2109 (COVID-19) vaccine uptake and determinants among people living with human immunodeficiency virus (PLHIV) in Federal Capital Territory (FCT), Nigeria.</p><p><strong>Methods: </strong>This was a cross-sectional study among PLHIV attending antiretroviral therapy clinics in FCT, Nigeria. We utilized an interviewer-administered, semi-structured questionnaire to collect data on COVID-19 vaccine uptake. Vaccine uptake was measured using the question 'Have you received a COVID-19 vaccine?' and was confirmed with a vaccination card by the interviewer. Data were analysed using descriptive statistics, χ2 and binary logistic regressions in Stata version 18.0.</p><p><strong>Results: </strong>Of the 252 study participants, 87 (34.5%) had received at least one dose of a COVID-19 vaccine, with uptake lower in females than males (30.5% vs 46.1%; p=0.022). Being >50 y of age (adjusted odds ratio [aOR] 2.870 [95% confidence interval {CI} 1.049 to 7.858], p=0.040) was associated with higher vaccine uptake, while being virally unsuppressed (aOR 0.313 [95% CI 0.099 to 0.985], p=0.047) and not believing COVID-19 disease is real (aOR 0.324 [95% CI 0.147 to 0.717], p=0.005) were associated with lower odds of vaccine uptake.</p><p><strong>Conclusions: </strong>Vaccination uptake was low among PLHIV in our study. It is critical to target vaccination campaigns to PLHIV, particularly females and younger people. Proper education about COVID-19 itself would contribute to vaccine uptake.</p>","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":" ","pages":"210-220"},"PeriodicalIF":1.9000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rates and determinants of COVID-19 vaccine uptake among people living with HIV in Federal Capital Territory, Nigeria.\",\"authors\":\"Victoria Peter Etuk, Charity Sanni, Oluwafemi Omonijo, Stella Ijioma Atema, Temitayo Lawal, Anthonia Murna Yashim-Ankut, Ifeyinwa Ejinkeonye, Henry Chijioke Onyegbutulem, Oyewole K Oyedele, Imoiboho Williams, Nifarta Peingurta Andrew, Evaezi Okpokoro\",\"doi\":\"10.1093/trstmh/trae094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>We investigated coronavirus disease 2109 (COVID-19) vaccine uptake and determinants among people living with human immunodeficiency virus (PLHIV) in Federal Capital Territory (FCT), Nigeria.</p><p><strong>Methods: </strong>This was a cross-sectional study among PLHIV attending antiretroviral therapy clinics in FCT, Nigeria. We utilized an interviewer-administered, semi-structured questionnaire to collect data on COVID-19 vaccine uptake. Vaccine uptake was measured using the question 'Have you received a COVID-19 vaccine?' and was confirmed with a vaccination card by the interviewer. Data were analysed using descriptive statistics, χ2 and binary logistic regressions in Stata version 18.0.</p><p><strong>Results: </strong>Of the 252 study participants, 87 (34.5%) had received at least one dose of a COVID-19 vaccine, with uptake lower in females than males (30.5% vs 46.1%; p=0.022). Being >50 y of age (adjusted odds ratio [aOR] 2.870 [95% confidence interval {CI} 1.049 to 7.858], p=0.040) was associated with higher vaccine uptake, while being virally unsuppressed (aOR 0.313 [95% CI 0.099 to 0.985], p=0.047) and not believing COVID-19 disease is real (aOR 0.324 [95% CI 0.147 to 0.717], p=0.005) were associated with lower odds of vaccine uptake.</p><p><strong>Conclusions: </strong>Vaccination uptake was low among PLHIV in our study. It is critical to target vaccination campaigns to PLHIV, particularly females and younger people. Proper education about COVID-19 itself would contribute to vaccine uptake.</p>\",\"PeriodicalId\":23218,\"journal\":{\"name\":\"Transactions of The Royal Society of Tropical Medicine and Hygiene\",\"volume\":\" \",\"pages\":\"210-220\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transactions of The Royal Society of Tropical Medicine and Hygiene\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/trstmh/trae094\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transactions of The Royal Society of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/trstmh/trae094","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Rates and determinants of COVID-19 vaccine uptake among people living with HIV in Federal Capital Territory, Nigeria.
Background: We investigated coronavirus disease 2109 (COVID-19) vaccine uptake and determinants among people living with human immunodeficiency virus (PLHIV) in Federal Capital Territory (FCT), Nigeria.
Methods: This was a cross-sectional study among PLHIV attending antiretroviral therapy clinics in FCT, Nigeria. We utilized an interviewer-administered, semi-structured questionnaire to collect data on COVID-19 vaccine uptake. Vaccine uptake was measured using the question 'Have you received a COVID-19 vaccine?' and was confirmed with a vaccination card by the interviewer. Data were analysed using descriptive statistics, χ2 and binary logistic regressions in Stata version 18.0.
Results: Of the 252 study participants, 87 (34.5%) had received at least one dose of a COVID-19 vaccine, with uptake lower in females than males (30.5% vs 46.1%; p=0.022). Being >50 y of age (adjusted odds ratio [aOR] 2.870 [95% confidence interval {CI} 1.049 to 7.858], p=0.040) was associated with higher vaccine uptake, while being virally unsuppressed (aOR 0.313 [95% CI 0.099 to 0.985], p=0.047) and not believing COVID-19 disease is real (aOR 0.324 [95% CI 0.147 to 0.717], p=0.005) were associated with lower odds of vaccine uptake.
Conclusions: Vaccination uptake was low among PLHIV in our study. It is critical to target vaccination campaigns to PLHIV, particularly females and younger people. Proper education about COVID-19 itself would contribute to vaccine uptake.
期刊介绍：
Transactions of the Royal Society of Tropical Medicine and Hygiene publishes authoritative and impactful original, peer-reviewed articles and reviews on all aspects of tropical medicine.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
